Early release, low float biotech, impressive tech fully
Top 10 Most Recent News Articles
BAILOR Welcomes Co-Founder Bob Bailor to Coach Academy
A New Chapter for a Seasoned Entrepreneur There's a certain irony in a seasoned business vet stepping into a new role at his own daughter's company, and that's exactly what's unfolding with the Bailors. Huntsville's own BAILOR isn't just another growth strategy company; it's the embodiment of a father-daughter dream team. After years as the ordinary head honcho, Bob...
Continue Reading
STARMUS VIII Merges Science and Art for Change
STARMUS VIII: Where Science and Art Collide Think about this: you're basking in the Canary Islands' sun, surrounded by Nobel laureates and astronauts while the riffs of Queen's Sir Brian May soar in the air. That's exactly what went down at STARMUS VIII, a week-long celebration of science and art held in Tenerife and La Palma from October 17 to 22, 2026. A jamboree of...
Continue Reading
Cohen Veterans Network Invites Americans to Honor Veterans
Cohen Veterans Network Launches "Call to Honor" Initiative The struggle to adequately acknowledge the sacrifices of veterans isn't new, but Cohen Veterans Network (CVN) is trying something a little different this time. "Call to Honor," a gratitude hotline, isn't just another method of saying "thanks"—it's a more profound communication channel for Americans to express...
Continue Reading
Air Force Officer's Pretrial Solitary Challenged
High Stakes at Joint Base Anacostia-Bolling Let's get real, the courtroom showdown set for November 17 over at Joint Base Anacostia-Bolling isn’t just another blip on the radar. We're talking about Major Jason P. Watson, a seasoned Air Force officer with an unblemished track record and more tours than most folks care to count. Monument Legal is at his side, hammering at...
Continue Reading
OneMain Holdings' Q3 2026: Mixed Signals in Nonprime Sector
Third Quarter Earnings: A Double-Edged Sword OneMain Holdings, Inc. (NYSE: OMF) rolled its Q3 2026 numbers out, and they look like a classic cocktail of high hopes and looming risks. On the surface, a diluted EPS of $1.60 might not sound like a knockout punch to the jaw, but let’s not forget they’ve taken a step back from last year’s $1.67. Their net income of $185...
Continue Reading
Trump Quotation Book Takes Unbiased Approach
In the ever-evolving dance of political discourse, a new book strides onto the stage: Not My President, published by Palmetto Publishing. It’s a bold compilation of presidential utterances, capturing the words of Donald J. Trump in all their unvarnished glory. Stripped of analysis or comedic flair, each entry stands alone like a solitary figure at a cocktail party,...
Continue Reading
Kansas City Life Welcomes Kellie Needham to Board
A New Era in Kansas City Life's Leadership This ain't your run-of-the-mill board appointment, folks. Kansas City Life Insurance Company has just handed the reins to Kellie S. Needham, who steps in to fill her mother's recently vacated board seat. Imagine that—a family legacy stretching back to the early 1900s when J.B. Reynolds first laid the foundation. Legacy Unbroken...
Continue Reading
Anthropic's IPO Preparations Stir Investor Curiosity
Anthropic's Entrance: A New Horizon in AI Investment Gritty times afoot in the tech trenches, and Anthropic's prepping for an IPO ain't just a blip on the radar—it's a sledgehammer moment for folks keeping their eye on AI. Leverage Shares, through their Themes branch, are sniffing out opportunities to create new investment products. They're tiptoeing around launching...
Continue Reading
TXNM Energy's Q3 2026 Hits Hard Amid Heat and M&A
TXNM Energy: A Strong Q3 2026 Amid Acquisition Waves Every so often, a company struts into earnings season and lays all its cards on the table. TXNM Energy just did that for Q3 2026, showing some robust numbers and setting tongues wagging on Wall Street. With GAAP earnings per diluted share shooting up to $1.50 from $1.22 the previous year, it's clear the power play is...
Continue Reading
Midterms and Retirement: Evaluate Precious Metals
Understanding the Financial Climate Amid Midterms Here we go, folks—the red, white, and blue circus we know as the midterms is back in town. And while politicians do their song and dance, you gotta ask yourself if your investments are strong enough to weather any storm those election winds might blow your way. American Independence Gold is waving the flag, telling folks...
Continue ReadingTop 5 Most Recently Viewed Articles
Experience Delight at Hundredfold American Brasserie
Introducing Hundredfold: A New American Brasserie Patina Group is excited to announce the debut of Hundredfold, a vibrant new American Brasserie set to open in Belmont Park Village. This innovative establishment, developed with renowned chef Timothy Hollingsworth, presents a fresh take on the classic French brasserie, merging warm hospitality with a touch of American...
Continue Reading
BioArctic's Key Contributions to Alzheimer's Research Unveiled
BioArctic's Key Contributions to Alzheimer's Research Unveiled At the upcoming Clinical Trials for Alzheimer's Disease Conference (CTAD), held from late October to early November, the spotlight will shine brightly on the groundbreaking efforts of BioArctic AB's founder Lars Lannfelt. He is set to receive the Lifetime Achievement Award for his extensive contributions to...
Continue Reading
Westlake University Launches Groundbreaking Astronomy Department
Westlake University Opens New Astronomy Department Westlake University, located in China, has proudly announced the creation of its Department of Astronomy at Yungu Campus, marking a significant milestone in the realm of academic research. This department, which is the first of its kind in a new type of research university in the country, is positioned to advance the...
Continue Reading
Mazdutide Achieves Significant Advances in Diabetes Treatment
Innovent's Mazdutide: Pioneering Diabetes Care Innovent Biologics has made remarkable strides in the treatment of type 2 diabetes and obesity through their innovative drug, mazdutide. In a groundbreaking Phase 3 clinical trial known as DREAMS-3, mazdutide showcased its effectiveness, proving its superiority over semaglutide in glycemic control and weight management. The...
Continue Reading
Mall of America Survey Highlights Back-to-School Shifts
Back-to-School Shopping Evolves with Family Experiences It turns out back-to-school shopping isn't just a budget drill anymore. Families are chasing deals, sure, but they're also looking for a bit more sparkle around the edges. Tossing a crumpled study into the ring, folks at the Mall of America have captured a handful of interesting behavior shifts. Turns out, making...
Continue Reading